New York, NY -- (SBWIRE) -- 04/21/2021 -- The Global Acute Respiratory Distress Syndrome (ARDS) market size was valued at USD 618.82 Million in 2019 and is expected to reach USD 990.88 Million by the year 2027, growing at a CAGR of 6% through the forecast period. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body organs, which at the end impact the appropriate functioning of the parts. Various causes are included with the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in the airway.

According to a survey done by the World Health Organization (WHO), it is seen that more than 3 million people are effects due to acute respiratory distress syndrome. It can affect people of all ages. The main reason for the ARDS is air pollution, which is caused due to the emission by the vehicles. The harmful gases emitted are inhaled by the people thus leading to several problems.

Different strategic initiatives have been undertaken by the various players in the ARDS industry. For instance, on December 2018, Windtree Therapeutics, Inc. a biopharmaceutical company merged with CVie Therapeutics and launched AEROSURF, a combination drug/device product which is used to treat respiratory distress syndrome.

The Asia Pacific region is the highest-growing region from a geographical perspective in the acute respiratory distress syndrome market. Thus, the advancement in the healthcare sector is expected to propel the market growth. China, India, and Japan are driving the growth of the acute respiratory distress syndrome market in the Asia-pacific region with growth in the lung injury and brain damage due to the rise in the car accidents in this region.

Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2089

Further key findings from the report suggest

The market for acute respiratory distress syndrome is anticipated to grow at a CAGR of 8.3% in the Asia-Pacific, followed by North America and Europe, with 4.8% and 5.7% CAGR, respectively. Increasing chronic diseases and the rise in air pollution are the key factors to accelerate market growth during the forecast period across all regions.
As of 2018, the therapeutic device segment was valued at USD 291.9 Million and is expected to grow at a CAGR of 5.8% during the forecast period. Increasing preference for gastrointestinal bleeding and pulmonary fibrosis has been one of the reasons for the growth of the acute respiratory distress syndrome market.
Due to the ARDS, various complications related to the brain and lung are noticed. Neurological hypoxic brain damage is also one of the injury types, which is reported for acute respiratory distress syndrome.
The treatment of acute respiratory distress syndrome is Fibro Proliferate, resolution stage, recovery stage, and many more.
The Asia-Pacific is the largest region for the acute respiratory distress syndrome market due to the significant contribution from countries like China, Japan, India, and Korea due to the growing end-segment and sales channel industries.
Asia Pacific region is accounted for the third largest market share in 2017, due to consumption in well establishes and end-user segment industries.
Among the region, North America has the largest market share. The primary driver for the acute respiratory distress syndrome market in North America is the growing brain injury, thus owing to the increase in injury type segment for the ARDS market.
Key participants include Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech.

Browse Complete Report "Acute Respiratory Distress Syndrome (ARDS) Market" @ https://www.reportsanddata.com/report-detail/acute-respiratory-distress-syndrome-ards-market

For this report, Reports and Data have segmented the acute respiratory distress syndrome market based on device type, injury type, severity, treatment, sales channel, end user and region.

Device Type (Revenue in USD Million; Volume in Tons, 2016–2027)

Monitoring Devices
Diagnostic Devices
Blood Gas Analyzers
Pulse Oximeters
Spirometers
Capnography Devices
Other Diagnostic Devices
Therapeutic Devices
Mechanical Ventilators
Invasive And Non-invasive Ventilators
Drug Delivery Devices
Nebulizers
Humidifiers
PAP
Other Therapeutic Devices

Injury Type (Revenue in USD Million; Volume in Tons, 2016–2027)

Brain Injury
Lung Injury

Severity (Revenue in USD Million; Volume in Tons, 2016–2027)

Mild
Moderate
Severe

Treatment (Revenue in USD Million; Volume in Tons, 2016–2027)

Fibro Proliferate
Exudative Stage
Resolution Stage
Recovery Stage

Sales Channel (Revenue in USD Million; Volume in Tons, 2016–2027)

Direct Sales
Channel Sales

End User (Revenue in USD Million; Volume in Tons, 2016–2027)

Hospitals
Clinics
Ambulatory Service Centers
Other End Users

Regional Outlook (Revenue in USD Billion; 2017–2027)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

TOC -
Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2016 – 2026

Chapter 3. Indicative Metrics

Chapter 4. Acute Respiratory Distress Syndrome Segmentation & Impact Analysis

    4.1. Acute Respiratory Distress Syndrome Segmentation Analysis

    4.2. Pharmaceutical Industry Outlook

………….

Chapter 12. Competitive Landscape

    12.1. Market Revenue Share by Manufacturers

    12.2. Mergers & Acquisitions

    12.3. Market positioning

    12.4. Strategy Benchmarking

    12.5. Vendor Landscape

Chapter 13. Company Profiles

    13.1. Faron Pharmaceuticals

           13.1.1. Company Overview

           13.1.2. Financial Performance

           13.1.3. Product Insights

           13.1.4. Strategic Initiatives

    13.2. BioMarck Pharmaceuticals

           13.2.1. Company Overview

           13.2.2. Financial Performance

           13.2.3. Product Insights

           13.2.4. Strategic Initiatives

    13.3. GE Healthcare,

            13.3.1. Company Overview

            13.3.2. Financial Performance

            13.3.3. Product Insights

            13.3.4. Strategic Initiatives

    13.4. Hamilton Medical AG,

            13.4.1. Company Overview

            13.4.2. Financial Performance

            13.4.3. Product Insights

            13.4.4. Strategic Initiatives

    13.5. Smiths Medical

           13.5.1. Company Overview

           13.5.2. Financial Performance

           13.5.3. Product Insights

           13.5.4. Strategic Initiatives

Continued……….

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2089

The report is a qualitative and quantitative research study that offers key insights into the latest strategic steps and tactics undertaken by the industry players to gain a robust footing in the market. The report further offers strategic recommendations to the new and emerging players and established companies to help them overcome the barriers of the industry. The report also covers a comprehensive SWOT analysis and Porter's Five Forces analysis to offer a better understanding of the Acute Respiratory Distress Syndrome (ARDS) market and its competitive landscape.

Browse Related Reports –

Intravenous Immunoglobulin (IVIG) Market Trends

Molecular Diagnostics Market Growth

Sacral Neuromodulation Market Analysis

Implantable Ports Market Share

Clinical Laboratory Market Demand

Thank you for reading our report. For further inquiries or queries about customization, please get in touch with us. Our team will ensure the report you get is best suited to your needs.

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com